The Effectiveness of the Drug Siavit in the Conservative Treatment of the Destruction of the Vitreous Body
Abstract
The destruction of the vitreous body (DST) is a pathological process in which the normal structure of the vitreous body is disturbed, accompanied by its liquefaction and thickening of the fibrils.
DST often develops in older people against the background of atherosclerosis and general vascular diseases. The most common filamentous DST, but there can be destruction in the form of "gold" or "silver" rain.
DST does not belong to diseases that are dangerous to health, however, the development of dense, opaque opacities in the vitreous body significantly impairs the patient's quality of life, up to the development of stable depressive conditions associated with constant anxiety.
The drugs used for DST are not effective enough and the attitude towards them is ambiguous. Recently, in the treatment of DST, the drug Siavit (Seavit) has been used, which is a source of micronutrients for the vitreous body. This drug was developed taking into account the metabolic disorders occurring in the vitreous body in older people. The article is devoted to the study of the effectiveness of the drug "Seavit" (LLC "ASEPTICA", Uzbekistan) in the destruction of the vitreous body (DST).
References
2. Johnson D., Hollands H. Acute-onset floaters and flashes // CMAJ, 2012; 184 (4): 431.link
3. Sharma P., Sridhar J., Mehta S. Flashes and Floaters // Prim Care, 2015; 42 (3): 425-435.link
4. Makhacheva ZA New in the anatomy of the vitreous body. - M., 2006.
5. Sebag J., Balazs E. A. Morphology and ultrastructure of human vitreous fibers // Invest Ophthalmol, 1989; 30 (8): 1867-1871. Link
6. Lagase J. P. Theory of retinal defocus change and the progression of myopia // Bulletin of optometry. - 2011. - 1. - 48-57.
7. Khvatova AV, Fridman FE, Katargina LA The state of the vitreous body in children with congenital uveitis // Bulletin of ophthalmology. - 1990. - T. 106, No. 5. - S. 43-45.
8. Guseva MR Features of the course of uveitis in children // Russian children's ophthalmology. - 2013. - No. 1. - P. 22-25.
9. Efendiev NM Contusional hemorrhages in the eye environment and changes in some biochemical parameters in the CT after experimental administration of autologous blood: Author's abstract. dis. ... Cand. honey. sciences. - Baku, 1966 .-- S. 29.
10. Sinav S., Demirci A., Sinav B., Oge F., Sullu Y, Kandemir B. A. Primary Intraocular Hydatid Cyst // Acta Ophthalmol (Copenh), 1991; 69 (6): 802-804.link
11. Duker J., Peter K., Binder S., D de Smet M., Gaudric A., Reichel E., Sadda S., Sebag J., Spaide R., Stalmans P. The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole // Ophthalmology, 2013; 120 (12): 2611-2619.link
12. Milston R., Madigan M. C., Sebag J. Vitreous floaters: Etiology, diagnostics, and management // Surv Ophthalmol, 2016; 61 (2): 211-227. Link
13. Averyanov DA, Alpatov SA, Bukina VV et al. Optical coherence tomography in ophthalmology. - Irkutsk, 2005 .-- 167 p.
14. Doga A. V., Buryakov D. A., Normaev B. A. Floating opacities of the vitreous body: modern approaches to treatment // Surgery News, 2018. - No. 4.
15. Nguyen J. H., Nguyen-Cuu J., Yu F., et al. Assessment of Vitreous Structure and Visual Function after Neodymium: Yttrium-Aluminum-Garnet Laser Vitreolysis // Ophthalmology, 2019; 126 (11): 1517-1526. Link
16. Luo J., An X., Kuang Y. Efficacy and safety of yttrium-aluminum garnet (YAG) laser vitreolysis for vitreous floaters // J Int Med Res., 2018; 46 (11): 4465-4471. Link
17. Mura M., Barca F. 25-Gauge vitrectomy // Dev Ophthalmol, 2014; 54: 45-53. link
18. Zakharov V. D. Vitreoretinal surgery. - M., 2003 .-- 173 p.
19. Hollands H., Johnson D., Brox A. C., Almeida D., Simel D. L., Sharma S. Acute-onset floaters and flashes: is this patient at risk for retinal detachment // JAMA, 2009; 302 (20): 2243-2249. Link.
